New cancer drug combo tested for safety in advanced tumors
NCT ID NCT00600496
Summary
This early-stage study aims to find out if combining an experimental oral drug called AZD6244 with standard chemotherapy is safe and tolerable for people with advanced solid tumors like breast, colon, lung, and kidney cancer. Researchers will test different doses to find the highest one patients can handle without severe side effects. They will also measure how the body absorbs and processes the drug combination and check for any early signs that the treatment might help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Detroit, Michigan, 48201, United States
-
Research Site
Philadelphia, Pennsylvania, 19111, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.